)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
Altimmune
Altimmune (ALT) investor relations material
Altimmune AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary16 Apr, 2026
Opening remarks and agenda
Meeting called to order virtually, enabling broader shareholder participation.
Formal business outlined in the notice and proxy statement mailed to shareholders.
Directors, officers, auditors, and legal counsel introduced at the start.
Corporate governance
Voting limited to shareholders of record as of March 13, 2026, with procedures for proxy and web portal ballots explained.
Quorum established with 88,270,241 shares represented out of 130,105,177 entitled to vote.
Inspector of Election appointed to tabulate results and ensure compliance.
Board and executive committee updates
Nine nominees for director positions presented for election to serve one-year terms.
No shareholder nominations for directors received in compliance with bylaws.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Altimmune
- Proxy covers director elections, auditor ratification, compensation, and capital structure changes.ALT
Proxy Filing17 Mar 2026 - Pemvidutide advances with strong MASH data, AI-driven phase III, and expanding late-stage pipeline.ALTBarclays 28th Annual Global Healthcare Conference12 Mar 2026
- Pemvidutide advances to phase III for MASH, with strong efficacy, tolerability, and regulatory support.ALTLeerink Global Healthcare Conference 202611 Mar 2026
- Pemvidutide advances to phase III in MASH, targeting efficacy, tolerability, and market differentiation.ALTThe Citizens Life Sciences Conference 202610 Mar 2026
- Pemvidutide shows robust efficacy and safety in liver disease, advancing to Phase 3 trials.ALTCorporate presentation10 Mar 2026
- Board seeks approval for director elections, auditor, compensation, and key charter amendments.ALTProxy Filing6 Mar 2026
- Phase 3 MASH trial set for 2026 after strong data, FDA support, and robust cash position.ALTQ4 20255 Mar 2026
- Q2 net loss reached $24.6M as pemvidutide advanced in obesity and MASH trials.ALTQ2 20242 Feb 2026
- Pemvidutide shows robust efficacy and safety in obesity and MASH, with pivotal data due next year.ALTGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
Next Altimmune earnings date
Q1 202612 May, 2026
Altimmune
Next Altimmune earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage